My NCBI | Sign In
Search: Hare CB[au]
RSS Settings
  • Search: Hare CB[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 16

    1.

    Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006.

    Marquez C, Mitchell SJ, Hare CB, John M, Klausner JD.

    AIDS Care. 2009 May;21(5):575-82.PMID: 19444665 [PubMed - indexed for MEDLINE]Related articles

    2.

    Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007.

    Zetola NM, Bernstein K, Ahrens K, Marcus JL, Philip S, Nieri G, Jones D, Hare CB, Hsu L, Scheer S, Klausner JD.

    BMC Public Health. 2009 Jan 14;9:17.PMID: 19144168 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The deadliest catch: fishing for HIV in new waters.

    Pilcher CD, Hare CB.

    Ann Intern Med. 2008 Aug 5;149(3):204-5. No abstract available. PMID: 18678848 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The essentials of HIV: a review for nurses.

    Petroll AE, Hare CB, Pinkerton SD.

    J Infus Nurs. 2008 Jul-Aug;31(4):228-35. Review.PMID: 18641486 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-June 2007.

    Zetola NM, Grijalva CG, Gertler S, Hare CB, Kaplan B, Dowling T, Colfax G, Katz MH, Klausner JD.

    PLoS One. 2008 Jul 2;3(7):e2591.PMID: 18596933 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.

    Hare CB, Mellors J, Krambrink A, Su Z, Skiest D, Margolis DM, Patel SS, Barnas D, Frenkel L, Coombs RW, Aweeka F, Morse GD, Haas DW, Boltz V, Palmer S, Coffin J, Havlir DV.

    Clin Infect Dis. 2008 Aug 1;47(3):421-4.PMID: 18558886 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence.

    Shoptaw S, Klausner JD, Reback CJ, Tierney S, Stansell J, Hare CB, Gibson S, Siever M, King WD, Kao U, Dang J.

    BMC Public Health. 2006 Aug 18;6:214.PMID: 16919170 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The safety and tolerability of Z-100 in patients infected with HIV-1.

    Borucki M, Holodniy M, Pierone G Jr, Ruane P, Steinhart C, Williams S, Slom T, Palella F Jr, Hare CB, Yoshidao Y, Li XD, Pollard RB.

    Antivir Ther. 2006;11(3):297-303.PMID: 16759045 [PubMed - indexed for MEDLINE]Related articles

    9.

    Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.

    Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, Bentsen C, Ramstead CA, Nixon DF, Levy JA, Hecht FM.

    Clin Infect Dis. 2006 Mar 1;42(5):700-8. Epub 2006 Jan 23.PMID: 16447118 [PubMed - indexed for MEDLINE]Related articles

    10.

    Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.

    Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, Havlir D, Peters M.

    J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):31-6.PMID: 16340470 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparison of characteristics of treated and non-treated patients with Hepatitis C infection.

    Hare CB, Morris JA, Chu A, Gotz V, Loveland JJ, Hodes D, Klaskala W.

    Pharmacoepidemiol Drug Saf. 2006 Feb;15(2):71-6.PMID: 16136612 [PubMed - indexed for MEDLINE]Related articles

    12.

    Primary HIV Infection.

    Hare CB, Kahn JO.

    Curr Infect Dis Rep. 2004 Feb;6(1):65-71.PMID: 14733851 [PubMed - as supplied by publisher]Related articles

    13.

    Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.

    Hare CB, Vu MP, Grunfeld C, Lampiris HW.

    Clin Infect Dis. 2002 Nov 15;35(10):e111-2. Epub 2002 Oct 25.PMID: 12410494 [PubMed - indexed for MEDLINE]Related articles

    14.

    Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents.

    Coggins CA, Elion GB, Houghton PJ, Hare CB, Keir S, Colvin OM, Bigner DD, Friedman HS.

    Cancer Chemother Pharmacol. 1998;41(6):485-90.PMID: 9554593 [PubMed - indexed for MEDLINE]Related articles

    15.

    Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft.

    Hare CB, Elion GB, Colvin OM, Ali-Osman F, Griffith OW, Petros WP, Keir S, Marcelli SL, Bigner DD, Friedman HS.

    Cancer Chemother Pharmacol. 1997;40(5):409-14.PMID: 9272117 [PubMed - indexed for MEDLINE]Related articles

    16.

    Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts.

    Hare CB, Elion GB, Houghton PJ, Houghton JA, Keir S, Marcelli SL, Bigner DD, Friedman HS.

    Cancer Chemother Pharmacol. 1997;39(3):187-91.PMID: 8996518 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    5 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity